Carrick Therapeutics: Funding, Investors & Team (Sep 2026)
Carrick Therapeutics is pioneering a portfolio of unique, first in class, cancer treatments that target driver mechanisms of the most aggressive forms of cancer, and which will be tailored to an individual patient’s tumour. Targeting the molecular pathways that drive the most aggressive and resistant forms of cancer will transform the way that cancer is treated and have a major impact on the lives of cancer patients. By linking a network of clinicians and scientists in internationally leading research institutes and hospitals, Carrick will streamline the introduction of these ground-breaking cancer therapies into the clinic, thus serving cancer patients around the world.
Carrick Therapeutics has raised $35.0M across 1 funding round on record, the most recent an undisclosed round of $35.0M announced in Dec 2022.
That round is above the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Carrick Therapeutics Company Profile and Key Stats
Latest funding round on record: Dec 2022.
Carrick Therapeutics Funding Rounds
Carrick Therapeutics Founders and Leadership Team
Contact details for the Carrick Therapeutics team: 1 of 1 has an email address on file.
Start 14-day free trial →Carrick Therapeutics Funding Compared to Other Biotechnology Startups
Carrick Therapeutics' latest round of $35.0M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Carrick Therapeutics in Biotechnology and Dublin
Companies Similar to Carrick Therapeutics
Luminate Medical develops a medical device designed to prevent hair loss during chemotherapy. Luminate…
Antler Bio employs gene expression data to assist in herd management and provides services for analyzing…
Nemysis unique strategy is a staged approach to the development of OTC and Prescription Products, tackling…
Perfuze was founded in 2018 by Wayne Allen and Liam Mullins. Perfuze is located within Galway City in the…
Neuromod is a medical device company formed to advance the science of bi-modal neuromodulation. We are…
Relevium Medical is a biopharmaceutical company with offices in both Ireland and the US that aims to enhance…
Ovagen Group Limited is a veterinary company based out of Ballina, Mayo, Ireland.
SOMAÍ is committed to building a strong global brand offering innovative cannabis-based therapeutics, aimed…
Beyondbmi offers specialized doctors and nutritionists who focus on managing weight, as well as the most…
Amara Therapeutics is passionate about empowering women and men to take control of their pelvic health. Amara…
Medical device company developing a closure device for vascular access procedures.
Impedans furnish you with astute detecting stages for radio-recurrence (RF) and plasma process checking.…
Carrick Therapeutics Funding FAQs
What does Carrick Therapeutics do?
Carrick Therapeutics is pioneering a portfolio of unique, first in class, cancer treatments that target driver mechanisms of the most aggressive forms of cancer, and which will be tailored to an individual patient’s tumour. Targeting the molecular pathways that drive the most aggressive and resistant forms of cancer will transform the way that cancer is treated and have a major impact on the lives of cancer patients. By linking a network of clinicians and scientists in internationally leading research institutes and hospitals, Carrick will streamline the introduction of these ground-breaking cancer therapies into the clinic, thus serving cancer patients around the world.
How much funding has Carrick Therapeutics raised?
Carrick Therapeutics has raised $35.0M across 1 round on record. The most recent is an undisclosed round of $35.0M announced in Dec 2022.
When did Carrick Therapeutics last raise funding?
Carrick Therapeutics' most recent funding round on record is an undisclosed round of $35.0M, announced in Dec 2022.
Who is the CEO of Carrick Therapeutics?
Anthony Brown is listed as CEO at Carrick Therapeutics.
Where is Carrick Therapeutics headquartered?
Carrick Therapeutics is based in Dublin, Ireland.
How many employees does Carrick Therapeutics have?
Carrick Therapeutics is in the 51-100 employee band.
How does Carrick Therapeutics' funding compare to other Biotechnology startups?
Carrick Therapeutics' latest round of $35.0M is above the $8.0M median round size for Biotechnology companies on FundedIQ across 4,179 tracked companies over the last two years.
About FundedIQ's Carrick Therapeutics Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Carrick Therapeutics is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.